{"id":14774,"date":"2013-07-18T16:30:53","date_gmt":"2013-07-18T20:30:53","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=14774"},"modified":"2013-07-18T16:30:53","modified_gmt":"2013-07-18T20:30:53","slug":"scripps-institute-sigma-aldrich-to-partner-on-reagents","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=14774","title":{"rendered":"Scripps Institute, Sigma-Aldrich to Partner on Reagents"},"content":{"rendered":"
\"Beakers<\/a>
(Research.gov)<\/figcaption><\/figure>\n

Scripps Research Institute<\/a> in La Jolla, California is collaborating with Sigma-Aldrich Corp.<\/a> in St. Louis to speed the availability of new chemical reagents for drug discovery to the scientific community. The deal calls for payments to Scripps from Sigma-Aldrich, a chemical and laboratory services company, although the size of the payments is not disclosed.<\/p>\n

Under the agreement,\u00a0Sigma-Aldrich will receive an exclusive license to commercialize new reagents developed in six labs at Scripps: Phil Baran<\/a>, Carlos Barbas<\/a>, Benjamin Cravatt<\/a>,\u00a0Phillip Dawson<\/a>,\u00a0Barry Sharpless<\/a>, and Jin-Quan Yu<\/a>. The research conducted in the labs covers various aspects of chemistry, biochemistry, and molecular biology.<\/p>\n

Sigma-Aldrich will provide payments to Scripps for the research conducted in the labs that results in the discovery of new reagent compounds. The company will also assign a product number to each of the new reagents, and make them available to the research community on the same day as their publication in scientific journals.<\/p>\n

Scripps and Sigma-Aldrich are already partnering on commercializing a collection of 10 zinc-based salts<\/a> developed in the lab of Phil Baran. Scripps says one of the salts, a difluoromethylation reagent, is being used in large quantities by pharmaceutical companies for optimizing lead compounds.<\/p>\n

In the past year, Scripps also established research collaborations with Janssen Pharmaceuticals<\/a> and Bristol-Myers Squibb<\/a>. This new deal is the first multi-lab partnership for Scripps with Sigma-Aldrich, or any other chemical supplier.<\/p>\n

Read more:<\/p>\n